Markets:

Overview

News

Currencies

International

Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

78.89 -0.58 (-0.74%)

Streaming Delayed Price Updated: 9:34 AM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock

May 12, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock

May 11, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

Stocks Reverse Gains Ahead Of Slew Of Inflation Data ↗

May 08, 2023

Stocks are lower this afternoon, as investors await a deluge of inflation data amid a rally for the banking sector.

Via Talk Markets

Why ANI Pharmaceuticals Stock Is Soaring Today ↗

May 08, 2023

ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q1 revenues were $106.8 million, +65.6% Y/Y, beating the

Via Benzinga

Earnings Preview For ANI Pharmaceuticals ↗

May 05, 2023

Via Benzinga

ANI Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗

March 13, 2023

Via Benzinga

ANI Pharmaceuticals's Return On Capital Employed Overview ↗

December 12, 2022

Via Benzinga

Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 08, 2023

Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 08, 2023

Via Benzinga

ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

May 08, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET

April 27, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

April 26, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP

April 24, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP

April 04, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance

March 09, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch ↗

March 01, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗

March 01, 2023

Via Benzinga

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET

February 22, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

Organon Stock Scores Market Leadership With Jump To 83 RS Rating ↗

January 17, 2023

Organon sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP

December 19, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP

November 28, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 16, 2022

Via Benzinga

ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP

November 16, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues

November 09, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET

October 24, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer

September 12, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗

September 07, 2022

Upgrades

Via Benzinga

ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

August 30, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP

August 29, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 16, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.